pharma

Uncategorized

High Courts Should Not Intervene in SARFAESI Proceedings Unless Actions Are Clearly Illegal or Mala Fide: Allahabad High Court

/

In a recent judgment, the Allahabad High Court emphasized that judicial intervention in matters governed by the Securitisation and Reconstruction of Financial Assets and Enforcement of Security Interest (SARFAESI) Act, 2002, should be limited to instances where banks have acted either unlawfully or with mala fide intent. The division bench, comprising Justice Shekhar B. Saraf […]

Uncategorized

India Sees 310% Rise in Patent Filings by Startups and MSMEs in Last Five Years

/

India has witnessed an extraordinary increase in patent filings by startups and micro, small, and medium enterprises (MSMEs), with data revealing a 310% growth over the past five years. This surge underscores the country’s growing focus on innovation, research, and intellectual property protection among emerging businesses. According to recent government and industry data, this dramatic

Uncategorized

India Strengthens Its Global Standing in AI and Patent Innovation: Nasscom’s Patent Pulse 2025 Report

/

As World Intellectual Property (IP) Day is observed globally, India has emerged as a prominent player in the international innovation ecosystem. India maintained its rank as the fifth-largest patent filer worldwide in FY24, with over 90,000 patents submitted—a milestone marking seven consecutive years of growth. A notable portion of these patents, more than 25%, are

Uncategorized

SK bioscience Claims Final Victory in mRNA Patent Dispute Against Moderna

/

South Korea’s SK bioscience, the biopharmaceutical subsidiary of SK Group, announced on Wednesday that it has secured a decisive win in a patent dispute against U.S.-based biotechnology company Moderna, known globally for its development of mRNA COVID-19 vaccines. The legal challenge, initiated in 2023, contested Moderna’s South Korean patent concerning the use and modification of

Uncategorized

ToolGen Initiates UK Patent Lawsuit Against Vertex Over Groundbreaking Gene Therapy CASGEVY

/

ToolGen, Inc. (KOSDAQ: 199800), a biotechnology firm at the forefront of genome editing innovations, has filed a patent infringement lawsuit in the United Kingdom against Vertex Pharmaceuticals and its key manufacturing partners, Lonza and RoslinCT. The legal action centers on Vertex’s approved CRISPR-based gene therapy, CASGEVY, which ToolGen alleges utilizes its proprietary technology without proper

Uncategorized

USPTO Suspends Expedited Examination for Design Applications Amid Fraud Concerns and Case Backlog

/

In a decisive move aimed at improving efficiency and safeguarding the integrity of the U.S. intellectual property system, the United States Patent and Trademark Office (USPTO) has announced the suspension of expedited examination for design patent applications, effective April 17, 2025. The policy change was officially detailed in a notice published in the USPTO’s Official

Uncategorized

New Guide Offers Strategic Insights to Strengthen Drug Patent Applications for Pharma Innovators

/

In a move designed to bridge the gap between pharmaceutical research and market success, a newly released guide is offering strategic advice to drug developers on how to craft more effective patent applications. Published on the widely respected platform DrugPatentWatch, the guide is titled “Drafting Effective Drug Patent Applications: Turning Science into Market Power” and

Uncategorized

Delhi High Court Denies Roche Injunction Against Natco, Puts Public Health Over Patent in Rare Disease Drug Case

/

The case, centered on Roche’s high-priced drug risdiplam used to treat Spinal Muscular Atrophy (SMA), brought public health and drug affordability to the forefront of the legal discourse. Justice Mini Pushkarna, delivering the verdict on March 24, underscored the primacy of public health in patent litigation involving critical medications. “Public health is not something that

Uncategorized

Biodegradable Plastics Enter the Mainstream as Global Patent Race Heats Up, Says Questel Report

/

With plastic pollution reaching critical levels, a growing number of innovators and companies are racing to develop sustainable alternatives. A new patent landscape analysis from Questel, led by chemistry specialist and business intelligence consultant Donia Ben Zakour, offers a comprehensive look into the evolving world of biodegradable plastics—and the findings suggest a wave of green

Uncategorized

China Sees Sharp Decline in Invention Patent Grants in Q1 2025, Reflecting Shift Toward Patent Quality Over Quantity

/

China’s National Intellectual Property Administration (CNIPA) released new statistics on April 15, 2025, revealing a significant decline in invention patent grants during the first quarter of the year. According to the official data, the number of invention patents granted between January and March 2025 dropped by 20.99% year-on-year, amounting to a reduction of 52,870 patents,

Scroll to Top